Targeting Metabolic Liver Disorders with Sodium Orthovanadate: A Novel Therapeutic Strategy. Current Pharmaceutical Research, [S. l.], v. 1, n. 3, p. 274–284, 2025. DOI: 10.63785/cpr.2025.1.3.274284. Disponível em: https://cpr.org.in/index.php/files/article/view/171. Acesso em: 15 jan. 2026.